Keywords
Last Name
Institution

Valentin Fuster

TitleDIRECTOR Zena and Michael A. Wiener Cardiovascular Institute
InstitutionMount Sinai
Address1190 Fifth Avenue
Floor 1
New York NY 10029
Phone212-241-7911
Fax212-423-9488
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentCardiology


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Céspedes J, Briceño G, Farkouh ME, Vedanthan R, Baxter J, Leal M, Boffetta P, Hunn M, Dennis R, Fuster V. Promotion of Cardiovascular Health in Preschool Children: 36-Month Cohort Follow-up. Am J Med. 2013 Dec; 126(12):1122-6.
      View in: PubMed
    2. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation. J Am Coll Cardiol. 2013 Dec 3; 62(22):2046-72.
      View in: PubMed
    3. Allijn IE, Leong W, Tang J, Gianella A, Mieszawska AJ, Fay F, Ma G, Russell S, Callo CB, Gordon RE, Korkmaz E, Post JA, Zhao Y, Gerritsen HC, Thran A, Proksa R, Daerr H, Storm G, Fuster V, Fisher EA, Fayad ZA, Mulder WJ, Cormode DP. Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level. ACS Nano. 2013 Nov 26; 7(11):9761-70.
      View in: PubMed
    4. Abdallah MS, Wang K, Magnuson EA, Spertus JA, Farkouh ME, Fuster V, Cohen DJ. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA. 2013 Oct 16; 310(15):1581-90.
      View in: PubMed
    5. Sanz G, Fuster V. Prevention: Polypills for cardiovascular prevention: a step forward? Nat Rev Cardiol. 2013 Dec; 10(12):683-4.
      View in: PubMed
    6. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JH, Tawakol A, Farkouh ME, Fayad ZA. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. JACC Cardiovasc Imaging. 2013 Oct; 6(10):1087-94.
      View in: PubMed
    7. Elmariah S, Budoff MJ, Delaney JA, Hamirani Y, Eng J, Fuster V, Kronmal RA, Halperin JL, O'Brien KD. Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis. Am Heart J. 2013 Nov; 166(5):904-12.
      View in: PubMed
    8. Hutter R, Huang L, Speidl WS, Giannarelli C, Trubin P, Bauriedel G, Klotman ME, Fuster V, Badimon JJ, Klotman PE. Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation. 2013 Nov 26; 128(22):2351-63.
      View in: PubMed
    9. Ibanez B, Macaya C, Sánchez-Brunete V, Pizarro G, Fernández-Friera L, Mateos A, Fernández-Ortiz A, García-Ruiz JM, García-Álvarez A, Iñiguez A, Jiménez-Borreguero J, López-Romero P, Fernández-Jiménez R, Goicolea J, Ruiz-Mateos B, Bastante T, Arias M, Iglesias-Vázquez JA, Rodriguez MD, Escalera N, Acebal C, Cabrera JA, Valenciano J, Pérez de Prado A, Fernández-Campos MJ, Casado I, García-Rubira JC, García-Prieto J, Sanz-Rosa D, Cuellas C, Hernández-Antolín R, Albarrán A, Fernández-Vázquez F, de la Torre-Hernández JM, Pocock S, Sanz G, Fuster V. Effect of Early Metoprolol on Infarct Size in ST-Segment-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial. Circulation. 2013 Oct 1; 128(14):1495-503.
      View in: PubMed
    10. Calcagno C, Ramachandran S, Izquierdo-Garcia D, Mani V, Millon A, Rosenbaum D, Tawakol A, Woodward M, Bucerius J, Moshier E, Godbold J, Kallend D, Farkouh ME, Fuster V, Rudd JH, Fayad ZA. The complementary roles of dynamic contrast-enhanced MRI and (18)F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging. 2013 Dec; 40(12):1884-93.
      View in: PubMed
    11. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2013 Sep 24; 62(13):1131-43.
      View in: PubMed
    12. Kahn MR, Robbins MJ, Kim MC, Fuster V. The role of fibrates in chronic kidney disease and diabetes mellitus. Nat Rev Cardiol. 2013 Sep; 10(9):547.
      View in: PubMed
    13. Arias T, Chen J, Fayad ZA, Fuster V, Hajjar RJ, Chemaly ER. Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. J Am Soc Echocardiogr. 2013 Aug; 26(8):910-8.
      View in: PubMed
    14. Hutter R, Speidl WS, Valdiviezo C, Sauter B, Corti R, Fuster V, Badimon JJ. Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1a activation: a novel aspect of angiogenesis in atherosclerosis. J Cardiovasc Transl Res. 2013 Aug; 6(4):558-69.
      View in: PubMed
    15. Bini J, Izquierdo-Garcia D, Mateo J, Machac J, Narula J, Fuster V, Fayad ZA. Preclinical evaluation of MR attenuation correction versus CT attenuation correction on a sequential whole-body MR/PET scanner. Invest Radiol. 2013 May; 48(5):313-22.
      View in: PubMed
    16. Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. 2013 Jul 2; 62(1):21-9.
      View in: PubMed
    17. Castellano JM, Vaishnava P, Castillo JG, Anyanwu AC, Fuster V. Coronary vasospasm attributable to fibromuscular dysplasia: the long bridge to transplant. Circ Heart Fail. 2013 May; 6(3):e31-2.
      View in: PubMed
    18. Farkouh ME, Boden WE, Bittner V, Muratov V, Hartigan P, Ogdie M, Bertolet M, Mathewkutty S, Teo K, Maron DJ, Sethi SS, Domanski M, Frye RL, Fuster V. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol. 2013 Apr 16; 61(15):1607-15.
      View in: PubMed
    19. Farkouh ME, Domanski M, Fuster V. Revascularization strategies in patients with diabetes. N Engl J Med. 2013 Apr 11; 368(15):1455-6.
      View in: PubMed
    20. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2013 May 7; 127(18):1916-26.
      View in: PubMed
    21. Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Le Heuzey JY, Kay GN, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 May 7; 61(18):1935-44.
      View in: PubMed
    22. Gorog DA, Fuster V. Platelet function tests in clinical cardiology: unfulfilled expectations. J Am Coll Cardiol. 2013 May 28; 61(21):2115-29.
      View in: PubMed
    23. Castillo JG, Castellano JM, Fuster V, Adams DH. A very unusual cause of mechanical left ventricular outflow tract obstruction. Eur J Cardiothorac Surg. 2013 Sep; 44(3):579-80.
      View in: PubMed
    24. Narula J, Nakano M, Virmani R, Kolodgie FD, Petersen R, Newcomb R, Malik S, Fuster V, Finn AV. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013 Mar 12; 61(10):1041-51.
      View in: PubMed
    25. Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013 Mar; 6(3):283-7.
      View in: PubMed
    26. Fuster V. Profile: The Centro Nacional de Investigaciones Cardiovasculares Carlos III. Interview by Emma Wilkinson. Eur Heart J. 2013 Mar; 34(10):705-6.
      View in: PubMed
    27. Kahn MR, Robbins MJ, Kim MC, Fuster V. Management of cardiovascular disease in patients with kidney disease. Nat Rev Cardiol. 2013 May; 10(5):261-73.
      View in: PubMed
    28. Chinitz JS, Vaishnava P, Narayan RL, Fuster V. Atrial fibrillation through the years: contemporary evaluation and management. Circulation. 2013 Jan 22; 127(3):408-16.
      View in: PubMed
    29. Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost. 2013 Jan; 11(1):100-6.
      View in: PubMed
    30. Sillesen H, Entrekin R, Garcia M, Falk E, Fuster V. Reply: To PMID 22789936. JACC Cardiovasc Imaging. 2013 Jan; 6(1):130.
      View in: PubMed
    31. Magnuson EA, Farkouh ME, Fuster V, Wang K, Vilain K, Li H, Appelwick J, Muratov V, Sleeper LA, Boineau R, Abdallah M, Cohen DJ. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation. 2013 Feb 19; 127(7):820-31.
      View in: PubMed
    32. Islami F, Pourshams A, Vedanthan R, Poustchi H, Kamangar F, Golozar A, Etemadi A, Khademi H, Freedman ND, Merat S, Garg V, Fuster V, Wakefield J, Dawsey SM, Pharoah P, Brennan P, Abnet CC, Malekzadeh R, Boffetta P. Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart. 2013 Feb; 99(4):272-8.
      View in: PubMed
    33. Kovacic JC, Fuster V. Smoking gun theory: angiographically normal or mild coronary plaque as a cause of myocardial infarction. Circulation. 2012 Dec 18; 126(25):2918-20.
      View in: PubMed
    34. Chatterjee S, Chaudhuri D, Vedanthan R, Fuster V, Ibanez B, Bangalore S, Mukherjee D. Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials. Int J Cardiol. 2013 Sep 30; 168(2):915-21.
      View in: PubMed
    35. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S, Bertrand M, Fuster V. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20; 367(25):2375-84.
      View in: PubMed
    36. Sanz G, Fuster V. Maximizing therapeutic envelope for prevention of cardiovascular disease: role of polypill. Mt Sinai J Med. 2012 Nov-Dec; 79(6):683-8.
      View in: PubMed
    37. Kovacic JC, Fuster V. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt Sinai J Med. 2012 Nov-Dec; 79(6):664-73.
      View in: PubMed
    38. Otsuka F, Fuster V, Narula J, Virmani R. Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. Mt Sinai J Med. 2012 Nov-Dec; 79(6):641-53.
      View in: PubMed
    39. Sillesen H, Fuster V. Predicting coronary heart disease: from Framingham Risk Score to ultrasound bioimaging. Mt Sinai J Med. 2012 Nov-Dec; 79(6):654-63.
      View in: PubMed
    40. Céspedes J, Briceño G, Farkouh ME, Vedanthan R, Baxter J, Leal M, Boffetta P, Woodward M, Hunn M, Dennis R, Fuster V. Targeting preschool children to promote cardiovascular health: cluster randomized trial. Am J Med. 2013 Jan; 126(1):27-35.e3.
      View in: PubMed
    41. Mirelis JG, Garcia-Alvarez A, Fernandez-Friera L, Sawit S, Hinojar R, Fuster V, García MJ, Sanz J. Respiratory ventricular area changes measured with real-time cardiac magnetic resonance: a new, accurate, and reproducible approach for the diagnosis of pericardial constriction. Int J Cardiol. 2013 Jun 5; 166(1):267-71.
      View in: PubMed
    42. Ibanez B, Fuster V, Macaya C, Sánchez-Brunete V, Pizarro G, López-Romero P, Mateos A, Jiménez-Borreguero J, Fernández-Ortiz A, Sanz G, Fernández-Friera L, Corral E, Barreiro MV, Ruiz-Mateos B, Goicolea J, Hernández-Antolín R, Acebal C, García-Rubira JC, Albarrán A, Zamorano JL, Casado I, Valenciano J, Fernández-Vázquez F, de la Torre JM, Pérez de Prado A, Iglesias-Vázquez JA, Martínez-Tenorio P, Iñiguez A. Study design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-segment elevation myocardial infarction. Am Heart J. 2012 Oct; 164(4):473-480.e5.
      View in: PubMed
    43. Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G, Lansky AJ, Cohen DJ, Magnuson EA, Ramanathan K, Tanguay JF, Muratov V, Sleeper LA, Domanski M, Bertrand ME, Fuster V. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am Heart J. 2012 Oct; 164(4):591-9.
      View in: PubMed
    44. Fuster V, Bhatt DL, Califf RM, Michelson AD, Sabatine MS, Angiolillo DJ, Bates ER, Cohen DJ, Coller BS, Furie B, Hulot JS, Mann KG, Mega JL, Musunuru K, O'Donnell CJ, Price MJ, Schneider DJ, Simon DI, Weitz JI, Williams MS, Hoots WK, Rosenberg YD, Hasan AA. Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group. Circulation. 2012 Sep 25; 126(13):1645-62.
      View in: PubMed
    45. Gangireddy SR, Halperin JL, Fuster V, Reddy VY. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Eur Heart J. 2012 Nov; 33(21):2700-8.
      View in: PubMed
    46. Purushothaman M, Krishnan P, Purushothaman KR, Baber U, Tarricone A, Perez JS, Wiley J, Kini A, Sharma SK, Fuster V, Moreno PR. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2769-75.
      View in: PubMed
    47. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2012 Sep 4; 60(10):932-42.
      View in: PubMed
    48. Chinitz JS, Halperin JL, Reddy VY, Fuster V. Rate or rhythm control for atrial fibrillation: update and controversies. Am J Med. 2012 Nov; 125(11):1049-56.
      View in: PubMed
    49. Yaniz-Galende E, Chen J, Chemaly E, Liang L, Hulot JS, McCollum L, Arias T, Fuster V, Zsebo KM, Hajjar RJ. Stem cell factor gene transfer promotes cardiac repair after myocardial infarction via in situ recruitment and expansion of c-kit+ cells. Circ Res. 2012 Nov 9; 111(11):1434-45.
      View in: PubMed
    50. Galper MW, Saung MT, Fuster V, Roessl E, Thran A, Proksa R, Fayad ZA, Cormode DP. Effect of computed tomography scanning parameters on gold nanoparticle and iodine contrast. Invest Radiol. 2012 Aug; 47(8):475-81.
      View in: PubMed
    51. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc Imaging. 2012 Aug; 5(8):819-28.
      View in: PubMed
    52. Kushner T, Halperin JL, Nair AP, Fuster V, Love BA. Peripheral pulmonary artery stenosis masquerading as pulmonary hypertension: a diagnostic and therapeutic challenge. Vasc Med. 2012 Aug; 17(4):235-8.
      View in: PubMed
    53. Elmariah S, Delaney JA, Bluemke DA, Budoff MJ, O'Brien KD, Fuster V, Kronmal RA, Halperin JL. Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2012 Aug; 5(8):781-8.
      View in: PubMed
    54. Purushothaman KR, Purushothaman M, Levy AP, Lento PA, Evrard S, Kovacic JC, Briley-Saebo KC, Tsimikas S, Witztum JL, Krishnan P, Kini A, Fayad ZA, Fuster V, Sharma SK, Moreno PR. Increased expression of oxidation-specific epitopes and apoptosis are associated with haptoglobin genotype: possible implications for plaque progression in human atherosclerosis. J Am Coll Cardiol. 2012 Jul 10; 60(2):112-9.
      View in: PubMed
    55. Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, Fuster V. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study. JACC Cardiovasc Imaging. 2012 Jul; 5(7):681-9.
      View in: PubMed
    56. Purushothaman KR, Krishnan P, Purushothaman M, Wiley J, Alviar CL, Ruiz FJ, Zubatov Y, Kini AS, Sharma SK, Fuster V, Moreno PR. Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization. Cardiovasc Pathol. 2013 Jan-Feb; 22(1):42-8.
      View in: PubMed
    57. Castillo JG, Anyanwu AC, Fuster V, Adams DH. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg. 2012 Aug; 144(2):308-12.
      View in: PubMed
    58. Bucerius J, Mani V, Moncrieff C, Rudd JH, Machac J, Fuster V, Farkouh ME, Fayad ZA. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012 Jun 5; 59(23):2080-8.
      View in: PubMed
    59. Castellano JM, Narayan RL, Vaishnava P, Fuster V. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nat Rev Cardiol. 2012 Jul; 9(7):415-24.
      View in: PubMed
    60. Fuster V, Chinitz JS. Net clinical benefit of warfarin: extending the reach of antithrombotic therapy for atrial fibrillation. Circulation. 2012 May 15; 125(19):2285-7.
      View in: PubMed
    61. Rosenson RS, Brewer HB, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation. 2012 Apr 17; 125(15):1905-19.
      View in: PubMed
    62. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation. 2012 Apr 10; 125(14):1795-808.
      View in: PubMed
    63. Castellano JM, Kovacic JC, Sanz J, Fuster V. Are we ignoring the dilated thoracic aorta? Ann N Y Acad Sci. 2012 Apr; 1254:164-74.
      View in: PubMed
    64. Kovacic JC, Castellano JM, Fuster V. Cardiovascular defense challenges at the basic, clinical, and population levels. Ann N Y Acad Sci. 2012 Apr; 1254:1-6.
      View in: PubMed
    65. Kovacic JC, Castellano JM, Fuster V. The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease. Ann N Y Acad Sci. 2012 Apr; 1254:99-105.
      View in: PubMed
    66. Chinitz JS, Castellano JM, Kovacic JC, Fuster V. Atrial fibrillation, stroke, and quality of life. Ann N Y Acad Sci. 2012 Apr; 1254:140-50.
      View in: PubMed
    67. Kovacic JC, Fuster V. Vascular calcification, diabetes, and cardiovascular disease: connecting the dots. JACC Cardiovasc Imaging. 2012 Apr; 5(4):367-9.
      View in: PubMed
    68. de Haas HJ, van den Borne SW, Boersma HH, Slart RH, Fuster V, Narula J. Evolving role of molecular imaging for new understanding: targeting myofibroblasts to predict remodeling. Ann N Y Acad Sci. 2012 Apr; 1254:33-41.
      View in: PubMed
    69. Stevens GR, Garcia-Alvarez A, Sahni S, Garcia MJ, Fuster V, Sanz J. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging. 2012 Apr; 5(4):378-87.
      View in: PubMed
    70. Dellegrottaglie S, Perrone-Filardi P, García-Alvarez A, Moral S, Stevens GR, Fuster V, Sanz J. Serial phase-contrast MRI for prediction of pulmonary hemodynamic changes in patients with pulmonary arterial hypertension. Int J Cardiol. 2012 May 17; 157(1):140-2.
      View in: PubMed
    71. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, McNamara CA. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res. 2012 Mar 16; 110(6):889-900.
      View in: PubMed
    72. Arbab-Zadeh A, Nakano M, Virmani R, Fuster V. Acute coronary events. Circulation. 2012 Mar 6; 125(9):1147-56.
      View in: PubMed
    73. Sawit ST, Garcia-Alvarez A, Suri B, Gaztanaga J, Fernandez-Friera L, Mirelis JG, D'Anca M, Fuster V, Sanz J, Garcia MJ. Usefulness of cardiac computed tomographic delayed contrast enhancement of the left atrial appendage before pulmonary vein ablation. Am J Cardiol. 2012 Mar 1; 109(5):677-84.
      View in: PubMed
    74. Narayan RL, Vaishnava P, Castellano JM, Fuster V. Quantitative assessment of right ventricular function in pectus excavatum. J Thorac Cardiovasc Surg. 2012 May; 143(5):e41-2.
      View in: PubMed
    75. Nair AP, Timoh T, Fuster V. Contemporary medical management of systolic heart failure. Circ J. 2012; 76(2):268-77.
      View in: PubMed
    76. Fuster V, Narula J. Risk factor update: old wine in a new bottle? Med Clin North Am. 2012 Jan; 96(1):xiii-xiv.
      View in: PubMed
    77. Hutter R, Badimon JJ, Fuster V, Narula J. Coronary artery disease in aging women: a menopause of endothelial progenitor cells? Med Clin North Am. 2012 Jan; 96(1):93-102.
      View in: PubMed
    78. Klink A, Heynens J, Herranz B, Lobatto ME, Arias T, Sanders HM, Strijkers GJ, Merkx M, Nicolay K, Fuster V, Tedgui A, Mallat Z, Mulder WJ, Fayad ZA. In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol. 2011 Dec 6; 58(24):2522-30.
      View in: PubMed
    79. Islami F, Manczuk M, Vedanthan R, Vatten L, Polewczyk A, Fuster V, Boffetta P, Zatonski WA. A cross-sectional study of cardiovascular disease and associated factors. Ann Agric Environ Med. 2011 Dec; 18(2):255-9.
      View in: PubMed
    80. Kovacic JC, Lee P, Baber U, Karajgikar R, Evrard SM, Moreno P, Mehran R, Fuster V, Dangas G, Sharma SK, Kini AS. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions. Atherosclerosis. 2012 Mar; 221(1):176-82.
      View in: PubMed
    81. Vaishnava P, Narayan R, Fuster V. Understanding systemic inflammation, oral hygiene, and cardiovascular disease. Am J Med. 2011 Nov; 124(11):997-9.
      View in: PubMed
    82. Bucerius J, Duivenvoorden R, Mani V, Moncrieff C, Rudd JH, Calcagno C, Machac J, Fuster V, Farkouh ME, Fayad ZA. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011 Nov; 4(11):1195-205.
      View in: PubMed
    83. Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K. The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectives. Am Heart J. 2011 Nov; 162(5):811-817.e1.
      View in: PubMed
    84. Domanski M, Lloyd-Jones D, Fuster V, Grundy S. Can we dramatically reduce the incidence of coronary heart disease? Nat Rev Cardiol. 2011 Dec; 8(12):721-5.
      View in: PubMed
    85. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov. 2011 Nov; 10(11):835-52.
      View in: PubMed
    86. Ibanez B, Giannarelli C, Cimmino G, Santos-Gallego CG, Alique M, Pinero A, Vilahur G, Fuster V, Badimon L, Badimon JJ. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type). Atherosclerosis. 2012 Jan; 220(1):72-7.
      View in: PubMed
    87. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging. 2011 Oct; 4(10):1100-9.
      View in: PubMed
    88. Falk E, Sillesen H, Muntendam P, Fuster V. The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population. Curr Atheroscler Rep. 2011 Oct; 13(5):359-66.
      View in: PubMed
    89. Fuster V, Kelly BB, Vedanthan R. Global cardiovascular health: urgent need for an intersectoral approach. J Am Coll Cardiol. 2011 Sep 13; 58(12):1208-10.
      View in: PubMed
    90. Sanz J, García-Alvarez A, Fernández-Friera L, Nair A, Mirelis JG, Sawit ST, Pinney S, Fuster V. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart. 2012 Feb; 98(3):238-43.
      View in: PubMed
    91. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011 Oct 29; 378(9802):1547-59.
      View in: PubMed
    92. Kovacic JC, Fuster V. From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020. Clin Pharmacol Ther. 2011 Oct; 90(4):509-18.
      View in: PubMed
    93. Fayad ZA, Mani V, Fuster V. The time has come for clinical cardiovascular trials with plaque characterization as an endpoint. Eur Heart J. 2012 Jan; 33(2):160-1.
      View in: PubMed
    94. Sanz J, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2011 Aug 16; 58(8):779-91.
      View in: PubMed
    95. Fayad ZA, Mani V, Woodward M, Kallend D, Bansilal S, Pozza J, Burgess T, Fuster V, Rudd JH, Tawakol A, Farkouh ME. Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Am Heart J. 2011 Aug; 162(2):214-221.e2.
      View in: PubMed
    96. Fernandez-Friera L, Garcia-Alvarez A, Guzman G, Bagheriannejad-Esfahani F, Malick W, Nair A, Fuster V, Garcia MJ, Sanz J. Apical right ventricular dysfunction in patients with pulmonary hypertension demonstrated with magnetic resonance. Heart. 2011 Aug; 97(15):1250-6.
      View in: PubMed
    97. Viles-Gonzalez JF, Fuster V, Halperin JL. New anticoagulants for prevention of stroke in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2011 Aug; 22(8):948-55.
      View in: PubMed
    98. García-Alvarez A, Fernández-Friera L, Mirelis JG, Sawit S, Nair A, Kallman J, Fuster V, Sanz J. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance. Eur Heart J. 2011 Oct; 32(19):2438-45.
      View in: PubMed
    99. Giannarelli C, Cimmino G, Connolly TM, Ibanez B, Ruiz JM, Alique M, Zafar MU, Fuster V, Feuerstein G, Badimon JJ. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur Heart J. 2012 Jan; 33(2):264-73.
      View in: PubMed
    100. Moral S, Fernández-Friera L, Stevens G, Guzman G, García-Alvarez A, Nair A, Evangelista A, Fuster V, Garcia MJ, Sanz J. New index a improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. Int J Cardiol. 2012 Nov 1; 161(1):25-30.
      View in: PubMed
    101. Kishore SP, Vedanthan R, Fuster V. Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries. J Am Coll Cardiol. 2011 May 17; 57(20):1980-7.
      View in: PubMed
    102. Garcia-Alvarez A, Fernandez-Friera L, Lau JF, Sawit ST, Mirelis JG, Castillo JG, Pinney S, Anyanwu AC, Fuster V, Sanz J, Garcia MJ. Evaluation of right ventricular function and post-operative findings using cardiac computed tomography in patients with left ventricular assist devices. J Heart Lung Transplant. 2011 Aug; 30(8):896-903.
      View in: PubMed
    103. Kovacic JC, Moreno P, Nabel EG, Hachinski V, Fuster V. Cellular senescence, vascular disease, and aging: part 2 of a 2-part review: clinical vascular disease in the elderly. Circulation. 2011 May 3; 123(17):1900-10.
      View in: PubMed
    104. Corti R, Fuster V. Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J. 2011 Jul; 32(14):1709-19b.
      View in: PubMed
    105. Fuster V, Kelly BB, Vedanthan R. Promoting global cardiovascular health: moving forward. Circulation. 2011 Apr 19; 123(15):1671-8.
      View in: PubMed
    106. Kovacic JC, Moreno P, Hachinski V, Nabel EG, Fuster V. Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation. 2011 Apr 19; 123(15):1650-60.
      View in: PubMed
    107. Moreno PR, Astudillo L, Elmariah S, Purushothaman KR, Purushothaman M, Lento PA, Sharma SK, Fuster V, Adams DH. Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis. J Thorac Cardiovasc Surg. 2011 Oct; 142(4):895-901.
      View in: PubMed
    108. Muntner P, Mann D, Wildman RP, Shimbo D, Fuster V, Woodward M. Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects. Am Heart J. 2011 Apr; 161(4):719-25.
      View in: PubMed
    109. Purushothaman KR, Purushothaman M, Muntner P, Lento PA, O'Connor WN, Sharma SK, Fuster V, Moreno PR. Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis. Vasc Med. 2011 Apr; 16(2):103-8.
      View in: PubMed
    110. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2011 Mar 15; 57(11):e101-98.
      View in: PubMed
    111. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC, Priori SG, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Tarkington LG, Yancy CW. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):e269-367.
      View in: PubMed
    112. Cimmino G, Giannarelli C, Chen W, Alique M, Santos-Gallego CG, Fuster V, Hajjar RJ, Walsh CE, Badimon JJ. Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration. J Cardiovasc Pharmacol. 2011 Mar; 57(3):325-33.
      View in: PubMed
    113. Fuster V, Sweeny JM. Aspirin: a historical and contemporary therapeutic overview. Circulation. 2011 Feb 22; 123(7):768-78.
      View in: PubMed
    114. Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Heuzey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011 Mar 15; 123(10):1144-50.
      View in: PubMed
    115. Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Heuzey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Mar; 8(3):e1-8.
      View in: PubMed
    116. Klink A, Hyafil F, Rudd J, Faries P, Fuster V, Mallat Z, Meilhac O, Mulder WJ, Michel JB, Ramirez F, Storm G, Thompson R, Turnbull IC, Egido J, Martín-Ventura JL, Zaragoza C, Letourneur D, Fayad ZA. Diagnostic and therapeutic strategies for small abdominal aortic aneurysms. Nat Rev Cardiol. 2011 Jun; 8(6):338-47.
      View in: PubMed
    117. Vaishnava P, Fuster V, Goldman M, Bonow RO. Surgery for asymptomatic degenerative aortic and mitral valve disease. Nat Rev Cardiol. 2011 Mar; 8(3):173-7.
      View in: PubMed
    118. Fernandez-Friera L, Garcia-Alvarez A, Bagheriannejad-Esfahani F, Malick W, Mirelis JG, Sawit ST, Fuster V, Sanz J, Garcia MJ, Hermann LK. Diagnostic value of coronary artery calcium scoring in low-intermediate risk patients evaluated in the emergency department for acute coronary syndrome. Am J Cardiol. 2011 Jan; 107(1):17-23.
      View in: PubMed
    119. Sanz G, Fuster V. Polypill and global cardiovascular health strategies. Semin Thorac Cardiovasc Surg. 2011; 23(1):24-9.
      View in: PubMed
    120. Viles-Gonzalez JF, Fuster V, Halperin J, Calkins H, Reddy VY. Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation. Clin Cardiol. 2011 Jan; 34(1):23-9.
      View in: PubMed
    121. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson SB, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann LS, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011 Jan 11; 57(2):223-42.
      View in: PubMed
    122. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011 Jan; 8(1):157-76.
      View in: PubMed
    123. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Jan 4; 123(1):104-23.
      View in: PubMed
    124. Giannarelli C, Ibanez B, Cimmino G, Garcia Ruiz JM, Faita F, Bianchini E, Zafar MU, Fuster V, Garcia MJ, Badimon JJ. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc Imaging. 2010 Dec; 3(12):1256-64.
      View in: PubMed
    125. Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases. Eur Heart J. 2011 Jun; 32(12):1561-71.
      View in: PubMed
    126. Ibanez B, Fuster V, Jiménez-Borreguero J, Badimon JJ. Lethal myocardial reperfusion injury: a necessary evil? Int J Cardiol. 2011 Aug 18; 151(1):3-11.
      View in: PubMed
    127. Elmariah S, Delaney JA, O'Brien KD, Budoff MJ, Vogel-Claussen J, Fuster V, Kronmal RA, Halperin JL. Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women MESA (The Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010 Nov 16; 56(21):1752-9.
      View in: PubMed
    128. Lobatto ME, Fayad ZA, Silvera S, Vucic E, Calcagno C, Mani V, Dickson SD, Nicolay K, Banciu M, Schiffelers RM, Metselaar JM, van Bloois L, Wu HS, Fallon JT, Rudd JH, Fuster V, Fisher EA, Storm G, Mulder WJ. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol Pharm. 2010 Dec 6; 7(6):2020-9.
      View in: PubMed
    129. Vedanthan R, Fuster V. Urgent need for human resources to promote global cardiovascular health. Nat Rev Cardiol. 2011 Feb; 8(2):114-7.
      View in: PubMed
    130. Fuster V, Sweeny JM. Clopidogrel and the reduced-function CYP2C19 genetic variant: a limited piece of the overall therapeutic puzzle. JAMA. 2010 Oct 27; 304(16):1839-40.
      View in: PubMed
    131. Fuster V, Vahl TP. The role of noninvasive imaging in promoting cardiovascular health. J Nucl Cardiol. 2010 Oct; 17(5):781-90.
      View in: PubMed
    132. Cimmino G, Ibanez B, Giannarelli C, Prat-González S, Hutter R, Garcia M, Sanz J, Fuster V, Badimon JJ. Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol. Int J Cardiol. 2011 Dec 15; 153(3):256-61.
      View in: PubMed
    133. Fuster V. Fine-tuning therapy for acute coronary syndromes. N Engl J Med. 2010 Sep 2; 363(10):976-7.
      View in: PubMed
    134. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, Fuster V, Fisher EA, Mulder WJ, Proksa R, Fayad ZA. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology. 2010 Sep; 256(3):774-82.
      View in: PubMed
    135. Muntendam P, McCall C, Sanz J, Falk E, Fuster V. The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectives. Am Heart J. 2010 Jul; 160(1):49-57.e1.
      View in: PubMed
    136. Farkouh ME, Fuster V. Diabetes: making sense of the rosiglitazone controversy. Nat Rev Cardiol. 2010 Jul; 7(7):366-7.
      View in: PubMed
    137. Osório J, Fuster V. Valve interventions-a word of caution. Nat Rev Cardiol. 2010 Jul; 7(7):355.
      View in: PubMed
    138. Lubitz SA, Benjamin EJ, Ruskin JN, Fuster V, Ellinor PT. Challenges in the classification of atrial fibrillation. Nat Rev Cardiol. 2010 Aug; 7(8):451-60.
      View in: PubMed
    139. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010 Jun 8; 55(23):2527-35.
      View in: PubMed
    140. Fuster V, Farkouh ME. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2010 Jun 8; 121(22):2450-2.
      View in: PubMed
    141. King A, Fuster V. Children are key to CVD prevention. Nat Rev Cardiol. 2010 Jun; 7(6):297.
      View in: PubMed
    142. Fuster V, Bansilal S. Promoting cardiovascular and cerebrovascular health. Stroke. 2010 Jun; 41(6):1079-83.
      View in: PubMed
    143. Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, Brennan DM, Hacke W, Montalescot G, Steinhubl SR, Topol EJ. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation. 2010 Jun 15; 121(23):2575-83.
      View in: PubMed
    144. Ibanez B, Fuster V. Ischaemic conditioning for myocardial salvage after AMI. Lancet. 2010 May 15; 375(9727):1691; author reply 1692.
      View in: PubMed
    145. Fuster V, Lois F, Franco M. Early identification of atherosclerotic disease by noninvasive imaging. Nat Rev Cardiol. 2010 Jun; 7(6):327-33.
      View in: PubMed
    146. Liao SL, Elmariah S, van der Zee S, Sealove BA, Fuster V. Does medical therapy for thoracic aortic aneurysms really work? Are beta-blockers truly indicated? CON. Cardiol Clin. 2010 May; 28(2):261-9.
      View in: PubMed
    147. Mearns BM, Fuster V. Highlight dementia risk to reduce CVD. Nat Rev Cardiol. 2010 May; 7(5):237.
      View in: PubMed
    148. Sanz J, Fuster V. Update in cardiology. Ann Intern Med. 2010 Jun 15; 152(12):786-91.
      View in: PubMed
    149. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2010 Apr 6; 55(14):1487-98.
      View in: PubMed
    150. Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, Khoueiry G, Lafferty J, McGinn JT, Brodman M, Fuster V, Hajjar RJ, Polgar K. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram. 2010 Apr; 12(2):117-25.
      View in: PubMed
    151. King A, Fuster V. Digital technology in cardiac care. Nat Rev Cardiol. 2010 Apr; 7(4):175-6.
      View in: PubMed
    152. Cañadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 1: pathophysiology and diagnosis. Nat Rev Cardiol. 2010 May; 7(5):256-65.
      View in: PubMed
    153. Cañadas V, Vilacosta I, Bruna I, Fuster V. Marfan syndrome. Part 2: treatment and management of patients. Nat Rev Cardiol. 2010 May; 7(5):266-76.
      View in: PubMed
    154. Speidl WS, Cimmino G, Ibanez B, Elmariah S, Hutter R, Garcia MJ, Fuster V, Goldman ME, Badimon JJ. Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. Eur Heart J. 2010 Aug; 31(16):2049-57.
      View in: PubMed
    155. Hayashi K, Mani V, Nemade A, Aguiar S, Postley JE, Fuster V, Fayad ZA. Variations in atherosclerosis and remodeling patterns in aorta and carotids. J Cardiovasc Magn Reson. 2010; 12:10.
      View in: PubMed
    156. Baber U, van der Zee S, Fuster V. Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation. Curr Cardiol Rep. 2010 Mar; 12(2):133-9.
      View in: PubMed
    157. Fuster V, Mearns BM. Global collaboration needed for AF. Nat Rev Cardiol. 2010 Mar; 7(3):115-6.
      View in: PubMed
    158. Underhill HR, Hatsukami TS, Fayad ZA, Fuster V, Yuan C. MRI of carotid atherosclerosis: clinical implications and future directions. Nat Rev Cardiol. 2010 Mar; 7(3):165-73.
      View in: PubMed
    159. Zafar MU, Paz-Yepes M, Shimbo D, Vilahur G, Burg MM, Chaplin W, Fuster V, Davidson KW, Badimon JJ. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J. 2010 Jul; 31(13):1573-82.
      View in: PubMed
    160. Fuster V, King A. The dual challenge of BP control. Nat Rev Cardiol. 2009 Dec; 6(12):729-30.
      View in: PubMed
    161. Love BA, Parness IA, Fuster V. Membranous septal aneurysm causing right ventricular outflow tract obstruction. Clin Cardiol. 2009 Dec; 32(12):E87.
      View in: PubMed
    162. Ibanez B, Cimmino G, Prat-González S, Vilahur G, Hutter R, García MJ, Fuster V, Sanz J, Badimon L, Badimon JJ. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol. 2011 Mar 17; 147(3):428-32.
      View in: PubMed
    163. Cimmino G, Chen W, Speidl WS, Giannarelli C, Ibanez B, Fuster V, Hajjar R, Walsh CE, Badimon JJ. Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer. J Cardiovasc Pharmacol. 2009 Nov; 54(5):405-11.
      View in: PubMed
    164. Mendis S, Fuster V. National policies and strategies for noncommunicable diseases. Nat Rev Cardiol. 2009 Nov; 6(11):723-7.
      View in: PubMed
    165. Fuster V, Mearns BM. The CVD paradox: mortality vs prevalence. Nat Rev Cardiol. 2009 Nov; 6(11):669.
      View in: PubMed
    166. Fishman ML, McLaughlin MA, Fuster V. Chronic renal insufficiency, cardiovascular disease and mortality in women: a causal relationship or coincidence? Womens Health (Lond Engl). 2009 Nov; 5(6):617-23.
      View in: PubMed
    167. Fuster V, van der Zee S, Miller MA. Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2009 Dec; 2(4):398-406.
      View in: PubMed
    168. Fuster V, Mearns BM. Lipid lowering: education is key. Nat Rev Cardiol. 2009 Oct; 6(10):609-10.
      View in: PubMed
    169. Fuster V. An ounce of prevention. Nat Rev Cardiol. 2009 Sep; 6(9):553-4.
      View in: PubMed
    170. Stevens GR, Lala A, Sanz J, Garcia MJ, Fuster V, Pinney S. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures. J Heart Lung Transplant. 2009 Sep; 28(9):899-905.
      View in: PubMed
    171. Sirol M, Moreno PR, Purushothaman KR, Vucic E, Amirbekian V, Weinmann HJ, Muntner P, Fuster V, Fayad ZA. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging. 2009 Sep; 2(5):391-6.
      View in: PubMed
    172. Fuster V. Are predictive risk scores useful? Nat Rev Cardiol. 2009 Aug; 6(8):493.
      View in: PubMed
    173. van der Zee S, Baber U, Elmariah S, Winston J, Fuster V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 2009 Sep; 6(9):580-9.
      View in: PubMed
    174. Moreno PR, Sanz J, Fuster V. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol. 2009 Jun 23; 53(25):2315-23.
      View in: PubMed
    175. Sipido KR, Tedgui A, Kristensen SD, Pasterkamp G, Schunkert H, Wehling M, Steg PG, Eisert W, Rademakers F, Casadei B, Fuster V, Cerbai E, Hasenfuss G, Fernandez-Aviles F, Garcia-Dorado D, Vidal M, Hallen M, Dambrauskaite V. Identifying needs and opportunities for advancing translational research in cardiovascular disease. Cardiovasc Res. 2009 Aug 1; 83(3):425-35.
      View in: PubMed
    176. Garcia MJ, Fuster V. An ounce of prevention with a calcium score scan? JACC Cardiovasc Imaging. 2009 Jun; 2(6):689-91.
      View in: PubMed
    177. Zafar MU, Farkouh ME, Fuster V, Chesebro JH. Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tablets. J Interv Cardiol. 2009 Aug; 22(4):385-9.
      View in: PubMed
    178. Floris-Moore M, Fayad ZA, Berman JW, Mani V, Schoenbaum EE, Klein RS, Weinshelbaum KB, Fuster V, Howard AA, Lo Y, Schecter AD. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS. 2009 May 15; 23(8):941-9.
      View in: PubMed
    179. Vedanthan R, Fuster V. Disease Prevention: The moving target of global cardiovascular health. Nat Rev Cardiol. 2009 May; 6(5):327-8.
      View in: PubMed
    180. Hulot JS, Fuster V. Antiplatelet therapy: Personalized medicine for clopidogrel resistance? Nat Rev Cardiol. 2009 May; 6(5):334-6.
      View in: PubMed
    181. Lipinski MJ, Frias JC, Amirbekian V, Briley-Saebo KC, Mani V, Samber D, Abbate A, Aguinaldo JG, Massey D, Fuster V, Vetrovec GW, Fayad ZA. Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis. JACC Cardiovasc Imaging. 2009 May; 2(5):637-47.
      View in: PubMed
    182. van der Zee S, Fuster V. [Cardiovascular disease and chronic kidney disease: from treatment to promoting health]. Med Clin (Barc). 2009 May; 132 Suppl 1:33-7.
      View in: PubMed
    183. Mani V, Muntner P, Gidding SS, Aguiar SH, El Aidi H, Weinshelbaum KB, Taniguchi H, van der Geest R, Reiber JH, Bansilal S, Farkouh M, Fuster V, Postley JE, Woodward M, Fayad ZA. Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events. J Cardiovasc Magn Reson. 2009; 11:10.
      View in: PubMed
    184. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, Fuster V, Fayad ZA. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis. 2009 Nov; 207(1):139-43.
      View in: PubMed
    185. Gorog DA, Sweeny JM, Fuster V. Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? Nat Rev Cardiol. 2009 May; 6(5):365-73.
      View in: PubMed
    186. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2009 Apr 14; 53(15):1326-37.
      View in: PubMed
    187. Sweeny JM, Gorog DA, Fuster V. Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements. Nat Rev Cardiol. 2009 Apr; 6(4):273-82.
      View in: PubMed
    188. Sanz J, Kariisa M, Dellegrottaglie S, Prat-González S, Garcia MJ, Fuster V, Rajagopalan S. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009 Mar; 2(3):286-95.
      View in: PubMed
    189. Fuster V, Bansilal S. JUPITER strikes earth. Nat Clin Pract Cardiovasc Med. 2009 Mar; 6(3):159.
      View in: PubMed
    190. Fuster V, van der Zee S, Elmariah S, Bonow RO. Academic careers in cardiovascular medicine. Circulation. 2009 Feb 10; 119(5):754-60.
      View in: PubMed
    191. Fuster V. Prime time for a polypill after myocardial infarction? Nat Clin Pract Cardiovasc Med. 2009 Feb; 6(2):83.
      View in: PubMed
    192. El Aidi H, Mani V, Weinshelbaum KB, Aguiar SH, Taniguchi H, Postley JE, Samber DD, Cohen EI, Stern J, van der Geest RJ, Reiber JH, Woodward M, Fuster V, Gidding SS, Fayad ZA. Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta. Nat Clin Pract Cardiovasc Med. 2009 Mar; 6(3):219-28.
      View in: PubMed
    193. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009 Mar; 2(2):107-15.
      View in: PubMed
    194. Thomas JD, Zoghbi WA, Beller GA, Bonow RO, Budoff MJ, Cerqueira MD, Creager MA, Douglas PS, Fuster V, Garcia MJ, Holmes DR, Manning WJ, Pohost GM, Ryan TJ, Van Decker WA, Wiegers SE. ACCF 2008 Training Statement on Multimodality Noninvasive Cardiovascular Imaging A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine. J Am Coll Cardiol. 2009 Jan 6; 53(1):125-46.
      View in: PubMed
    195. Farkouh ME, Fuster V. Diabetes and aspirin: beware of underpowered negative trials. Nat Clin Pract Cardiovasc Med. 2009 Jan; 6(1):1.
      View in: PubMed
    196. Sanz G, Fuster V. Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population. Nat Clin Pract Cardiovasc Med. 2009 Feb; 6(2):101-10.
      View in: PubMed
    197. Cimmino G, Ibanez B, Vilahur G, Speidl WS, Fuster V, Badimon L, Badimon JJ. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano). J Cell Mol Med. 2009 Sep; 13(9B):3226-35.
      View in: PubMed
    198. Hajjar R, Fuster V. Cardiac cell and gene therapies: two trajectories, one goal. Nat Clin Pract Cardiovasc Med. 2008 Dec; 5(12):749.
      View in: PubMed
    199. Worthley SG, Zhang ZY, Machac J, Helft G, Tang C, Liew GY, Zaman AG, Worthley MI, Fayad ZA, Buchsbaum MS, Fuster V, Badimon JJ. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009 Mar; 25(3):251-7.
      View in: PubMed
    200. Farkouh ME, Fuster V. Time to welcome the elderly into clinical trials. Nat Clin Pract Cardiovasc Med. 2008 Nov; 5(11):673.
      View in: PubMed
    201. Fuster V, Farkouh ME. Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel. Circulation. 2008 Oct 14; 118(16):1607-8.
      View in: PubMed
    202. Fuster V, Vedanthan R. Cardiovascular disease and the UN Millennium Development Goals: time to move forward. Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):593.
      View in: PubMed
    203. Moreno PR, Purushothaman KR, Purushothaman M, Muntner P, Levy NS, Fuster V, Fallon JT, Lento PA, Winterstern A, Levy AP. Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque. J Am Coll Cardiol. 2008 Sep 23; 52(13):1049-51.
      View in: PubMed
    204. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):621-35.
      View in: PubMed
    205. Sealove BA, Tiyyagura S, Fuster V. Takotsubo cardiomyopathy. J Gen Intern Med. 2008 Nov; 23(11):1904-8.
      View in: PubMed
    206. Fayad ZA, Fuster V. Prologue: relevance of molecular imaging in clinical medicine. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5 Suppl 2:S1.
      View in: PubMed
    207. Vedanthan R, Fuster V. Cardiovascular disease in Sub-Saharan Africa: a complex picture demanding a multifaceted response. Nat Clin Pract Cardiovasc Med. 2008 Sep; 5(9):516-7.
      View in: PubMed
    208. Mani V, Adler E, Briley-Saebo KC, Bystrup A, Fuster V, Keller G, Fayad ZA. Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med. 2008 Jul; 60(1):73-81.
      View in: PubMed
    209. Bansilal S, Farkouh ME, Fuster V. Optimal treatment of the diabetic patient with multivessel disease. Curr Cardiol Rep. 2008 Jul; 10(4):272-84.
      View in: PubMed
    210. Dellegrottaglie S, Sanz J, Fuster V, Rajagopalan S. Fatty infiltration of the right ventricle assessed by computed tomography and magnetic resonance imaging. J Cardiovasc Med (Hagerstown). 2008 Jul; 9(7):753.
      View in: PubMed
    211. Farkouh ME, Bansilal S, Fuster V. Failing to ENHANCE science. Nat Clin Pract Cardiovasc Med. 2008 Jul; 5(7):355.
      View in: PubMed
    212. Love BA, Mehta D, Fuster VF. Evaluation and management of the adult patient with transposition of the great arteries following atrial-level (Senning or Mustard) repair. Nat Clin Pract Cardiovasc Med. 2008 Aug; 5(8):454-67.
      View in: PubMed
    213. Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008 Jun 24; 117(25):3206-15.
      View in: PubMed
    214. Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, Rafique A, Hargeaves R, Farkouh M, Fuster V, Fayad ZA. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008 Jun; 49(6):871-8.
      View in: PubMed
    215. Calcagno C, Cornily JC, Hyafil F, Rudd JH, Briley-Saebo KC, Mani V, Goldschlager G, Machac J, Fuster V, Fayad ZA. Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol. 2008 Jul; 28(7):1311-7.
      View in: PubMed
    216. Fuster V, Camm H. Screening, stem cells, biomarkers and hypercholesterolemia: our first original clinical research. Nat Clin Pract Cardiovasc Med. 2008 May; 5(5):237.
      View in: PubMed
    217. Lubitz SA, Fischer A, Fuster V. Catheter ablation for atrial fibrillation. BMJ. 2008 Apr 12; 336(7648):819-26.
      View in: PubMed
    218. Ibanez B, Cimmino G, Bénézet-Mazuecos J, Santos-Gallego CG, Pinero A, Prat-González S, Speidl WS, Fuster V, García MJ, Sanz J, Badimon JJ. Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis. Atherosclerosis. 2009 Jan; 202(1):185-91.
      View in: PubMed
    219. Ibanez B, Vilahur G, Cimmino G, Speidl WS, Pinero A, Choi BG, Zafar MU, Santos-Gallego CG, Krause B, Badimon L, Fuster V, Badimon JJ. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol. 2008 Mar 18; 51(11):1104-9.
      View in: PubMed
    220. Worthley SG, Helft G, Corti R, Worthley MI, Chew DP, Fayad ZA, Zaman AG, Fallon JT, Fuster V, Badimon JJ. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb. 2007; 36(1):9-17.
      View in: PubMed
    221. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2008 Mar 4; 51(9):944-55.
      View in: PubMed
    222. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2008 Mar; 106(3):685-712.
      View in: PubMed
    223. Farkouh ME, Fuster V. Meta-analysis of small trials: proceed with caution. Nat Clin Pract Nephrol. 2008 Mar; 4(3):115.
      View in: PubMed
    224. Choi BG, Vilahur G, Zafar MU, Cardoso L, Yadegar D, Ibanez B, Tunstead J, Viles-Gonzalez JF, Schaffler MB, Fuster V, Badimon JJ. Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis. 2008 Nov; 201(1):76-84.
      View in: PubMed
    225. Choi BG, Vilahur G, Cardoso L, Fritton JC, Ibanez B, Zafar MU, Yadegar D, Speidl WS, Schaffler MB, Fuster V, Badimon JJ. Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway. Eur J Clin Invest. 2008 Apr; 38(4):211-7.
      View in: PubMed
    226. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S, Domanski M, McKinlay S, Fuster V. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008 Feb; 155(2):215-23.
      View in: PubMed
    227. Beller GA, Bonow RO, Fuster V. ACCF 2008 Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement). J Am Coll Cardiol. 2008 Jan 22; 51(3):335-8.
      View in: PubMed
    228. Elmariah S, Smith SC, Fuster V. Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction. Nat Clin Pract Cardiovasc Med. 2008 Jan; 5(1):42-52.
      View in: PubMed
    229. Farkouh ME, Fuster V. Meta-analysis of small trials: proceed with caution. Nat Clin Pract Cardiovasc Med. 2007 Dec; 4(12):635.
      View in: PubMed
    230. Miller MA, Gomes JA, Fuster V. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2007 Dec; 4(12):667-76.
      View in: PubMed
    231. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):e159-241.
      View in: PubMed
    232. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007 Oct 23; 50(17):1707-32.
      View in: PubMed
    233. Fuster V, Voute J, Hunn M, Smith SC. Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation. 2007 Oct 23; 116(17):1966-70.
      View in: PubMed
    234. O'Rourke RA, Fuster V. Sophisticated technology is not a substitute for cognitive cardiology. Nat Clin Pract Cardiovasc Med. 2007 Oct; 4(10):519.
      View in: PubMed
    235. Zafar MU, Vorchheimer DA, Gaztanaga J, Velez M, Yadegar D, Moreno PR, Kunitada S, Pagan J, Fuster V, Badimon JJ. Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber. Thromb Haemost. 2007 Oct; 98(4):883-8.
      View in: PubMed
    236. Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol. 2007 Dec; 27(12):2763-8.
      View in: PubMed
    237. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):e418-99.
      View in: PubMed
    238. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007 Oct 23; 116(17):1971-96.
      View in: PubMed
    239. Goldbarg SH, Elmariah S, Miller MA, Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol. 2007 Sep 25; 50(13):1205-13.
      View in: PubMed
    240. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, Fuster V, Fayad ZA. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007 Aug 28; 50(9):892-6.
      View in: PubMed
    241. Fuster V. A new perspective on nonprescription statins: an opportunity for patient education and involvement. Am J Cardiol. 2007 Sep 1; 100(5):907-10.
      View in: PubMed
    242. Fuster V, Farkouh ME. Faster publication isn't always better. Nat Clin Pract Cardiovasc Med. 2007 Jul; 4(7):345.
      View in: PubMed
    243. Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O'Donnell TP, Mehta D, Fuster V, Rajagopalan S. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol. 2007 Aug 15; 100(4):731-5.
      View in: PubMed
    244. Fuster V. Centres of excellence: a Spanish cardiovascular research initiative. Interview by Jennifer Taylor. Circulation. 2007 May 29; 115(21):f104-6.
      View in: PubMed
    245. Voûte J, Fuster V. Can adults at high-risk of cardiovascular disease be identified by screening their children for risk factors? Nat Clin Pract Cardiovasc Med. 2007 Jul; 4(7):360-1.
      View in: PubMed
    246. Levy AP, Purushothaman KR, Levy NS, Purushothaman M, Strauss M, Asleh R, Marsh S, Cohen O, Moestrup SK, Moller HJ, Zias EA, Benhayon D, Fuster V, Moreno PR. Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ Res. 2007 Jul 6; 101(1):106-10.
      View in: PubMed
    247. Farkouh ME, Bansilal S, Fuster V. Risk profiling patients for selective use of drug-eluting stents is warranted. Nat Clin Pract Cardiovasc Med. 2007 Jul; 4(7):346-7.
      View in: PubMed
    248. Ibanez B, Prat-González S, Speidl WS, Vilahur G, Pinero A, Cimmino G, García MJ, Fuster V, Sanz J, Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007 Jun 12; 115(23):2909-16.
      View in: PubMed
    249. Dellegrottaglie S, Einstein AJ, Sanz J, Zucker MJ, Fuster V, Rajagopalan S. Magnetic resonance imaging of a bioprosthetic mitral valve: a smiling heart. J Cardiovasc Med (Hagerstown). 2007 May; 8(5):394-5.
      View in: PubMed
    250. Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med. 2007 May; 13(5):636-41.
      View in: PubMed
    251. Sanz J, Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2007 Apr 24; 49(16):1740-9.
      View in: PubMed
    252. Farkouh ME, Greenberg JD, Jeger RV, Ramanathan K, Verheugt FW, Chesebro JH, Kirshner H, Hochman JS, Lay CL, Ruland S, Mellein B, Matchaba PT, Fuster V, Abramson SB. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis. 2007 Jun; 66(6):764-70.
      View in: PubMed
    253. Fuster V, Sanz G. A polypill for secondary prevention: time to move from intellectual debate to action. Nat Clin Pract Cardiovasc Med. 2007 Apr; 4(4):173.
      View in: PubMed
    254. Dellegrottaglie S, Sanz J, Poon M, Viles-Gonzalez JF, Sulica R, Goyenechea M, Macaluso F, Fuster V, Rajagopalan S. Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. Radiology. 2007 Apr; 243(1):63-9.
      View in: PubMed
    255. Lipinski MJ, Abbate A, Fuster V, Vetrovec GW. Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms. Nat Clin Pract Cardiovasc Med. 2007 Apr; 4(4):196-205.
      View in: PubMed
    256. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. [ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary]. Rev Port Cardiol. 2007 Apr; 26(4):383-446.
      View in: PubMed
    257. Fuster V, Voûte J. Expanding the cardiovascular mandate: from treatment to the protection of health. Nat Clin Pract Cardiovasc Med. 2007 Mar; 4(3):117.
      View in: PubMed
    258. Zafar MU, Farkouh ME, Osende J, Shimbo D, Palencia S, Crook J, Leadley R, Fuster V, Chesebro JH. Potent arterial antithrombotic effect of direct factor-Xa inhibition with ZK-807834 administered to coronary artery disease patients. Thromb Haemost. 2007 Mar; 97(3):487-92.
      View in: PubMed
    259. Bansilal S, Farkouh M, Sharma S, Fuster V. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting. Indian Heart J. 2007 Mar-Apr; 59(2 Suppl B):B72-82.
      View in: PubMed
    260. Sanz J, Kuschnir P, Rius T, Salguero R, Sulica R, Einstein AJ, Dellegrottaglie S, Fuster V, Rajagopalan S, Poon M. Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. Radiology. 2007 Apr; 243(1):70-9.
      View in: PubMed
    261. Escaned J, Rydén L, Zamorano JL, Poole-Wilson P, Fuster V, Gitt A, Fernández-Avilés F, Scholte Op Reimer W, de Teresa E, Alonso-Pulpón L, Tendera M. Trends and contexts in European cardiology practice for the next 15 years: the Madrid Declaration: a report from the European Conference on the Future of Cardiology, Madrid, 2-3 June 2006. Eur Heart J. 2007 Mar; 28(5):634-7.
      View in: PubMed
    262. Fuster V, Sanz J. Gene therapy and stem cell therapy for cardiovascular diseases today: a model for translational research. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S1-8.
      View in: PubMed
    263. Sanz J, Moreno PR, Fuster V. Update on advances in atherothrombosis. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4(2):78-89.
      View in: PubMed
    264. Choi BG, Novoselsky CA, Vilahur G, Viles-Gonzalez JF, Zafar MU, Ibanez B, Fuster V, Badimon JJ. Validation study of a semi-automated program for quantification of atherosclerotic burden. J Cardiovasc Magn Reson. 2007; 9(3):615-20.
      View in: PubMed
    265. Fuster V, Sanz J. Vascular inflammation. J Am Soc Hypertens. 2007 Jan-Feb; 1(1):68-81.
      View in: PubMed
    266. Nadal-Ginard B, Fuster V. Myocardial cell therapy at the crossroads. Nat Clin Pract Cardiovasc Med. 2007 Jan; 4(1):1.
      View in: PubMed
    267. Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ. Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost. 2007 Jan; 5(1):82-90.
      View in: PubMed
    268. Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol. 2007 Feb 19; 99(4A):6B-14B.
      View in: PubMed
    269. Spektor G, Gehi AK, Love B, Sharma SK, Fuster V. A case of symptomatic coronary artery fistula. Nat Clin Pract Cardiovasc Med. 2006 Dec; 3(12):689-92.
      View in: PubMed
    270. Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R, Guetta J, Yang C, Purushothaman KR, Fuster V, Moreno PR. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2007 Jan; 27(1):134-40.
      View in: PubMed
    271. Pucci A, Sheiban I, Formato L, Celeste A, Brscic E, Moretti C, De Bernardi A, Alberti A, Bergamasco L, Trevi G, Fuster V. In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. Atherosclerosis. 2007 Sep; 194(1):189-95.
      View in: PubMed
    272. Danik S, Fuster V. The obstetrical patient with a prosthetic heart valve. Obstet Gynecol Clin North Am. 2006 Sep; 33(3):481-91.
      View in: PubMed
    273. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):651-745.
      View in: PubMed
    274. Smith S, Voûte J, Fuster V. Principles for national and regional guidelines on cardiovascular disease prevention. Nat Clin Pract Cardiovasc Med. 2006 Sep; 3(9):461.
      View in: PubMed
    275. Lipinski MJ, Amirbekian V, Frias JC, Aguinaldo JG, Mani V, Briley-Saebo KC, Fuster V, Fallon JT, Fisher EA, Fayad ZA. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med. 2006 Sep; 56(3):601-10.
      View in: PubMed
    276. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol. 2006 Sep; 17(9):1383-97; quiz 1398.
      View in: PubMed
    277. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006 Aug 15; 48(4):854-906.
      View in: PubMed
    278. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Aug 15; 114(7):e257-354.
      View in: PubMed
    279. Fuster V. Cardiovascular disease and the UN millennium development goals: a serious concern. Nat Clin Pract Cardiovasc Med. 2006 Aug; 3(8):401.
      View in: PubMed
    280. Fuster V, Goldbarg SH, Hansalia RJ, Stevens GR, Tiyyagura SR. The inoperable valvular heart disease patient:the pluses and minuses of percutaneous valvular replacement. EuroIntervention. 2006 Aug; 2(2):154-60.
      View in: PubMed
    281. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med. 2006 Aug; 6(5):457-77.
      View in: PubMed
    282. Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis. Curr Mol Med. 2006 Aug; 6(5):489-99.
      View in: PubMed
    283. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med. 2006 Aug; 6(5):501-14.
      View in: PubMed
    284. Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr Mol Med. 2006 Aug; 6(5):549-56.
      View in: PubMed
    285. Sanz J, Dellegrottaglie S, Fuster V, Rajagopalan S. Calcium scoring and contrast-enhanced CT angiography. Curr Mol Med. 2006 Aug; 6(5):525-39.
      View in: PubMed
    286. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J. 2006 Aug; 27(16):1979-2030.
      View in: PubMed
    287. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006 Aug 1; 48(3):e1-148.
      View in: PubMed
    288. Moreno PR, Sanz J, Fuster V. Atherosclerosis. Curr Mol Med. 2006 Aug; 6(5):437-8.
      View in: PubMed
    289. Sirol M, Fuster V, Fayad ZA. Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med. 2006 Aug; 6(5):541-8.
      View in: PubMed
    290. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006 Aug 1; 114(5):e84-231.
      View in: PubMed
    291. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. Circulation. 2006 Jun 6; 113(22):2662-74.
      View in: PubMed
    292. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J Am Coll Cardiol. 2006 Jun 6; 47(11):2343-55.
      View in: PubMed
    293. Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, Rodriguez OJ, Buchsbaum MS, Fuster V, Badimon JJ. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006; 6:3.
      View in: PubMed
    294. Sanz J, Weeks D, Nikolaou K, Sirol M, Rius T, Rajagopalan S, Dellegrottaglie S, Strobeck J, Fuster V, Poon M. Detection of healed myocardial infarction with multidetector-row computed tomography and comparison with cardiac magnetic resonance delayed hyperenhancement. Am J Cardiol. 2006 Jul 15; 98(2):149-55.
      View in: PubMed
    295. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006 May 9; 113(18):2245-52.
      View in: PubMed
    296. Corti R, Osende J, Hutter R, Viles-Gonzalez JF, Zafar U, Valdivieso C, Mizsei G, Fallon JT, Fuster V, Badimon JJ. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis. 2007 Jan; 190(1):106-13.
      View in: PubMed
    297. Fuster V. The several faces of clinical trials: from new therapies to failed preventive strategies. Nat Clin Pract Cardiovasc Med. 2006 Apr; 3(4):173.
      View in: PubMed
    298. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 Mar 21; 47(6):1239-312.
      View in: PubMed
    299. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006 Mar 21; 113(11):e463-654.
      View in: PubMed
    300. Gibbons RJ, Fuster V. Therapy for patients with acute coronary syndromes--new opportunities. N Engl J Med. 2006 Apr 6; 354(14):1524-7.
      View in: PubMed
    301. Fuster V, Sanz J, Viles-Gonzalez JF, Rajagopalan S. The utility of magnetic resonance imaging in cardiac tissue regeneration trials. Nat Clin Pract Cardiovasc Med. 2006 Mar; 3 Suppl 1:S2-7.
      View in: PubMed
    302. Beller GA, Bonow RO, Fuster V. ACCF 2006 Update for Training in Adult Cardiovascular Medicine (Focused Update of the 2002 COCATS 2 Training Statement): A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Introduction. J Am Coll Cardiol. 2006 Feb 21; 47(4):894-7.
      View in: PubMed
    303. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neil WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Feb 21; 113(7):e166-286.
      View in: PubMed
    304. Winslow RD, Pinney S, Fuster V. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure. Nat Clin Pract Cardiovasc Med. 2006 Feb; 3(2):86-93.
      View in: PubMed
    305. Fayad ZA, Amirbekian V, Toussaint JF, Fuster V. Identification of interleukin-2 for imaging atherosclerotic inflammation. Eur J Nucl Med Mol Imaging. 2006 Feb; 33(2):111-6.
      View in: PubMed
    306. Fuster V. Novel cardiovascular biomarkers and implications for clinical trials. Nat Clin Pract Cardiovasc Med. 2006 Feb; 3(2):57.
      View in: PubMed
    307. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 3; 47(1):216-35.
      View in: PubMed
    308. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006 Jan 3; 47(1):e1-121.
      View in: PubMed
    309. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006 Jan 3; 113(1):156-75.
      View in: PubMed
    310. Trocciola SM, Dayal R, Chaer RA, Lin SC, DeRubertis B, Ryer EJ, Hynececk RL, Pierce MJ, Prince M, Badimon J, Marin ML, Fuster V, Kent KC, Faries PL. The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model. J Vasc Surg. 2006 Jan; 43(1):109-16.
      View in: PubMed
    311. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv. 2006 Jan; 67(1):87-112.
      View in: PubMed
    312. Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, Aguinaldo JG, Fayad ZA, Fuster V, Lippmann M, Chen LC, Rajagopalan S. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA. 2005 Dec 21; 294(23):3003-10.
      View in: PubMed
    313. Fuster V. Cardiovascular disease in the elderly: a challenge for science and clinical care. Nat Clin Pract Cardiovasc Med. 2005 Nov; 2(11):549.
      View in: PubMed
    314. Fuster V. Symposium presentations. How to become a cardiovascular investigator. J Am Coll Cardiol. 2005 Oct 4; 46(7 Suppl):A5-70.
      View in: PubMed
    315. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005 Oct 4; 46(7):1209-18.
      View in: PubMed
    316. Fuster V. Where am I going? The future of academic cardiovascular medicine. J Am Coll Cardiol. 2005 Oct 4; 46(7 Suppl):A1-4.
      View in: PubMed
    317. Fuster V, Voûte J. MDGs: chronic diseases are not on the agenda. Lancet. 2005 Oct 29-Nov 4; 366(9496):1512-4.
      View in: PubMed
    318. Ashton R, Fuster V. A promising start for Nature Clinical Practice Cardiovascular Medicine. Nat Clin Pract Cardiovasc Med. 2005 Oct; 2(10):491.
      View in: PubMed
    319. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005 Sep 20; 46(6):937-54.
      View in: PubMed
    320. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 Sep 20; 112(12):e154-235.
      View in: PubMed
    321. Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation. 2005 Sep 13; 112(11):1594-600.
      View in: PubMed
    322. Fuster V, Moreno PR. Atherothrombosis as a systemic, often silent, disease. Nat Clin Pract Cardiovasc Med. 2005 Sep; 2(9):431.
      View in: PubMed
    323. Gehi A, Haas D, Fuster V. Primary prophylaxis with the implantable cardioverter-defibrillator: the need for improved risk stratification. JAMA. 2005 Aug 24; 294(8):958-60.
      View in: PubMed
    324. Brandão AP, Brandão AA, Berenson GS, Fuster V. [Metabolic syndrome in children and adolescents]. Arq Bras Cardiol. 2005 Aug; 85(2):79-81.
      View in: PubMed
    325. Rhee JY, Trocciola SM, Dayal R, Lin S, Chaer R, Kumar N, Mousa A, Bernheim J, Christos P, Prince M, Marin ML, Gordon R, Badimon J, Fuster V, Kent KC, Faries PL. Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. J Vasc Surg. 2005 Aug; 42(2):321-8.
      View in: PubMed
    326. Couturier G, Voustaniouk A, Weinberger J, Fuster V. Correlation between coronary artery disease and aortic arch plaque thickness measured by non-invasive B-mode ultrasonography. Atherosclerosis. 2006 Mar; 185(1):159-64.
      View in: PubMed
    327. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005 Jul 5; 46(1):106-12.
      View in: PubMed
    328. Fuster V, Kim RJ. Frontiers in cardiovascular magnetic resonance. Circulation. 2005 Jul 5; 112(1):135-44.
      View in: PubMed
    329. Winslow RD, Mehta D, Fuster V. Sudden cardiac death: mechanisms, therapies and challenges. Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):352-60.
      View in: PubMed
    330. Fuster V. The evolving role of CT and MRI in atherothrombotic evaluation and management. Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):323.
      View in: PubMed
    331. Spektor G, Fuster V. Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now? Nat Clin Pract Cardiovasc Med. 2005 Jun; 2(6):290-300.
      View in: PubMed
    332. Fuster V. Atrial fibrillation: an epidemiologic, scientific and clinical challenge. Nat Clin Pract Cardiovasc Med. 2005 May; 2(5):225.
      View in: PubMed
    333. Sulica R, Dinh HV, Dunsky K, Fuster V, Poon M. The acute hemodynamic effect of IV nitroglycerin and dipyridamole in patients with pulmonary arterial hypertension: comparison with IV epoprostenol. Congest Heart Fail. 2005 May-Jun; 11(3):139-44; quiz 145-6.
      View in: PubMed
    334. Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Atherosclerosis. 2005 Sep; 182(1):79-85.
      View in: PubMed
    335. Wentzel JJ, Corti R, Fayad ZA, Wisdom P, Macaluso F, Winkelman MO, Fuster V, Badimon JJ. Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. J Am Coll Cardiol. 2005 Mar 15; 45(6):846-54.
      View in: PubMed
    336. Fuster V. Childhood: a critical focus for 'primordial prevention' research. Nat Clin Pract Cardiovasc Med. 2005 Mar; 2(3):113.
      View in: PubMed
    337. Sanz J, Rius T, Kuschnir P, Fuster V, Goldberg J, Ye XY, Wisdom P, Poon M. The importance of end-systole for optimal reconstruction protocol of coronary angiography with 16-slice multidetector computed tomography. Invest Radiol. 2005 Mar; 40(3):155-63.
      View in: PubMed
    338. Corti R, Badimon J, Mizsei G, Macaluso F, Lee M, Licato P, Viles-Gonzalez JF, Fuster V, Sherman W. Real time magnetic resonance guided endomyocardial local delivery. Heart. 2005 Mar; 91(3):348-53.
      View in: PubMed
    339. Viles-Gonzalez JF, Fuster V, Corti R, Valdiviezo C, Hutter R, Corda S, Anand SX, Badimon JJ. Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study. Eur Heart J. 2005 Aug; 26(15):1557-61.
      View in: PubMed
    340. Mousa A, Dayal R, Bernheim J, Henderson P, Hollenbeck S, Trocciola S, Prince M, Gordon R, Badimon J, Fuster V, Marin ML, Kent KC, Faries PL. A canine model to study the significance and hemodynamics of type II endoleaks. J Surg Res. 2005 Feb; 123(2):275-83.
      View in: PubMed
    341. Viles-Gonzalez JF, Fuster V. Looking for the culprit of coronary in-stent restenosis: debatable role for the fibrinolytic system? J Thromb Haemost. 2005 Feb; 3(2):230-2.
      View in: PubMed
    342. Adler E, Fuster V. SCN5A--a mechanistic link between inherited cardiomyopathies and a predisposition to arrhythmias? JAMA. 2005 Jan 26; 293(4):491-3.
      View in: PubMed
    343. Viles-Gonzalez JF, Fuster V, Badimon JJ. Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis. Am Heart J. 2005 Jan; 149(1 Suppl):S19-31.
      View in: PubMed
    344. Fuster V. Obesity: a challenge for science and society. Nat Clin Pract Cardiovasc Med. 2005 Jan; 2(1):1.
      View in: PubMed
    345. Moreno PR, Fuster V. New aspects in the pathogenesis of diabetic atherothrombosis. J Am Coll Cardiol. 2004 Dec 21; 44(12):2293-300.
      View in: PubMed
    346. Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol. 2004 Dec 7; 44(11):2099-110.
      View in: PubMed
    347. Sanz J, Rius T, Kuschnir P, Macaluso F, Fuster V, Poon M. Images in cardiovascular medicine. Double-chambered left ventricle: complete characterization by cardiac magnetic resonance and multidetector-row computed tomography. Circulation. 2004 Nov 16; 110(20):e502-3.
      View in: PubMed
    348. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med. 2004 Nov; 1(1):48-55.
      View in: PubMed
    349. Fuster V. Why do we need yet another journal? Nat Clin Pract Cardiovasc Med. 2004 Nov; 1(1):1.
      View in: PubMed
    350. Viles-Gonzalez JF, Choi BG, Fuster V, Badimon JJ. Peroxisome proliferator-activated receptor ligands in atherosclerosis. Expert Opin Investig Drugs. 2004 Nov; 13(11):1393-403.
      View in: PubMed
    351. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov. 2004 Nov; 3(11):913-25.
      View in: PubMed
    352. Jacobs AK, Lindsay BD, Bellande BJ, Fonarow GC, Nishimura RA, Shah PM, Annex BH, Fuster V, Gibbons RJ, Jackson MJ, Rahimtoola SH. Task force 3: Disclosure of relationships with commercial interests: policy for educational activities and publications. J Am Coll Cardiol. 2004 Oct 19; 44(8):1736-40.
      View in: PubMed
    353. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, Fuster V, Badimon JJ, Sauter BV. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation. 2004 Oct 19; 110(16):2430-5.
      View in: PubMed
    354. Corti R, Fuster V. Should standard medical therapy for angina include a statin? Clin Cardiol. 2004 Oct; 27(10):547-51.
      View in: PubMed
    355. Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic heart valves. Mt Sinai J Med. 2004 Oct; 71(5):322-9.
      View in: PubMed
    356. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, Badimon JJ, O'Connor WN. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004 Oct 5; 110(14):2032-8.
      View in: PubMed
    357. Viles-Gonzalez JF, Poon M, Sanz J, Rius T, Nikolaou K, Fayad ZA, Fuster V, Badimon JJ. In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis: comparison with magnetic resonance imaging and histopathology. Circulation. 2004 Sep 14; 110(11):1467-72.
      View in: PubMed
    358. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol. 2004 Sep 1; 44(5):e213-310.
      View in: PubMed
    359. Itskovich VV, Samber DD, Mani V, Aguinaldo JG, Fallon JT, Tang CY, Fuster V, Fayad ZA. Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images. Magn Reson Med. 2004 Sep; 52(3):515-23.
      View in: PubMed
    360. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004 Aug 31; 110(9):1168-76.
      View in: PubMed
    361. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation. 2004 Aug 31; 110(9):e82-292.
      View in: PubMed
    362. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, Badimon JJ, Fuster V, Corti R. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 2004 Aug 31; 110(9):1156-61.
      View in: PubMed
    363. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004 Aug 3; 110(5):588-636.
      View in: PubMed
    364. Fuster V, Hirshfeld JW, Brown AS, Brundage BH, Fye WB, Lewis RP, Nash IS, Sketch MH, Vetrovec GW. Working group 8: Defining the different types of cardiovascular specialists and developing a new model for training general clinical cardiologists. J Am Coll Cardiol. 2004 Jul 21; 44(2):267-71.
      View in: PubMed
    365. Ridker PM, Koenig W, Fuster V. C-reactive protein and coronary heart disease. N Engl J Med. 2004 Jul 15; 351(3):295-8; author reply 295-8.
      View in: PubMed
    366. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004 Jul; 25(14):1197-207.
      View in: PubMed
    367. Smith SC, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, Wood DA, Alderman M, Horgan J, Home P, Hunn M, Grundy SM. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation. 2004 Jun 29; 109(25):3112-21.
      View in: PubMed
    368. Sirol M, Itskovich VV, Mani V, Aguinaldo JG, Fallon JT, Misselwitz B, Weinmann HJ, Fuster V, Toussaint JF, Fayad ZA. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation. 2004 Jun 15; 109(23):2890-6.
      View in: PubMed
    369. Taylor AJ, Udelson JE, Fuster V. Training cardiovascular fellows in cardiovascular magnetic resonance and vascular imaging; Current status following the core cardiovascular training symposium (COCATS-2) guidelines. J Am Coll Cardiol. 2004 Jun 2; 43(11):2108-12.
      View in: PubMed
    370. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004 Jun 1; 109(21):2617-25.
      View in: PubMed
    371. Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, van der Steen AF. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004 Jun; 25(12):1077-82.
      View in: PubMed
    372. Viles-Gonzalez JF, Anand SX, Valdiviezo C, Zafar MU, Hutter R, Sanz J, Rius T, Poon M, Fuster V, Badimon JJ. Update in atherothrombotic disease. Mt Sinai J Med. 2004 May; 71(3):197-208.
      View in: PubMed
    373. Fayad ZA, Sirol M, Nikolaou K, Choudhury RP, Fuster V. Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque. Curr Atheroscler Rep. 2004 May; 6(3):232-42.
      View in: PubMed
    374. Viles-Gonzalez JF, Anand SX, Zafar MU, Fuster V, Badimon JJ. Tissue factor coagulation pathway: a new therapeutic target in atherothrombosis. J Cardiovasc Pharmacol. 2004 May; 43(5):669-76.
      View in: PubMed
    375. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Lüderitz B, Fallon JT, Fuster V, Badimon JJ. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation. 2004 Apr 27; 109(16):2001-8.
      View in: PubMed
    376. Osende JI, Shimbo D, Fuster V, Dubar M, Badimon JJ. Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist. J Thromb Haemost. 2004 Mar; 2(3):492-8.
      View in: PubMed
    377. Corti R, Osende JI, Fallon JT, Fuster V, Mizsei G, Jneid H, Wright SD, Chaplin WF, Badimon JJ. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004 Feb 4; 43(3):464-73.
      View in: PubMed
    378. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis. 2004 Feb; 17(1):35-44.
      View in: PubMed
    379. Jang JJ, Olin JW, Fuster V. A teenager with mixed connective tissue disease presenting with an acute coronary syndrome. Vasc Med. 2004 Feb; 9(1):31-4.
      View in: PubMed
    380. Viles-Gonzalez JF, Gaztanaga J, Zafar UM, Fuster V, Badimon JJ. Clinical and experimental experience with factor Xa inhibitors. Am J Cardiovasc Drugs. 2004; 4(6):379-84.
      View in: PubMed
    381. Rosenbluth A, Fuster V. Cholesterol-lowering studies for aortic stenosis. Adv Cardiol. 2004; 41:62-74.
      View in: PubMed
    382. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003 Oct 15; 42(8):1493-531.
      View in: PubMed
    383. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer CW, Stevenson WG, Tomaselli GF, Antman EM, Smith SC, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell RO, Priori SG, Blanc JJ, Budaj A, Burgos EF, Cowie M, Deckers JW, Garcia MA, Klein WW, Lekakis J, Lindahl B, Mazzotta G, Morais JC, Oto A, Smiseth O, Trappe HJ. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation. 2003 Oct 14; 108(15):1871-909.
      View in: PubMed
    384. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003 Oct; 16(10):1091-110.
      View in: PubMed
    385. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol. 2003 Oct 1; 42(7):1318-33.
      View in: PubMed
    386. Olin JW, Fuster V. Acute aortic dissection: the need for rapid, accurate, and readily available diagnostic strategies. Arterioscler Thromb Vasc Biol. 2003 Oct 1; 23(10):1721-3.
      View in: PubMed
    387. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O'Gara PT, Carabello BA, Russell RO, Cerqueira MD, St John Sutton MG, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003 Sep 16; 108(11):1404-18.
      View in: PubMed
    388. Bauriedel G, Jabs A, Skowasch D, Hutter R, Badimon JJ, Fuster V, Welsch U, Lüderitz B. Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol. 2003 Sep 3; 42(5):930-8.
      View in: PubMed
    389. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003 Sep 2; 108(9):1146-62.
      View in: PubMed
    390. Bayés de Luna A, Tse TF, de Figueiredo MB, Maranhão M, Voûte J, Nishtar S, Fuster V, Poole-Wilson P. World Heart Day: a World Heart Federation enterprise promoting the prevention of heart disease and stroke across the world. Circulation. 2003 Sep 2; 108(9):1038-40.
      View in: PubMed
    391. Fayad ZA, Choudhury RP, Fuster V. Magnetic resonance imaging of coronary atherosclerosis. Curr Atheroscler Rep. 2003 Sep; 5(5):411-7.
      View in: PubMed
    392. Viles-Gonzalez JF, Fuster V, Corti R, Badimon JJ. Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes. Curr Opin Cardiol. 2003 Jul; 18(4):286-94.
      View in: PubMed
    393. Fuster V, Corti R, Fayad ZA, Schwitter J, Badimon JJ. Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. J Thromb Haemost. 2003 Jul; 1(7):1410-21.
      View in: PubMed
    394. MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: current status. Arterioscler Thromb Vasc Biol. 2003 Aug 1; 23(8):1333-42.
      View in: PubMed
    395. Gomberg-Maitland M, Fuster V, Fayad ZA, Badimon JJ, Corti R. Statins and plaque stability. J Cardiovasc Risk. 2003 Jun; 10(3):161-7.
      View in: PubMed
    396. Jneid H, Bhatt DL, Corti R, Badimon JJ, Fuster V, Francis GS. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med. 2003 May 26; 163(10):1145-53.
      View in: PubMed
    397. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003 May 7; 41(9):1633-52.
      View in: PubMed
    398. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation. 2003 Apr 29; 107(16):2068-71.
      View in: PubMed
    399. Halperin JL, Fuster V. Meeting the challenge of peripheral arterial disease. Arch Intern Med. 2003 Apr 28; 163(8):877-8.
      View in: PubMed
    400. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation. 2003 Apr 1; 107(12):1692-711.
      View in: PubMed
    401. Hutter R, Sauter BV, Reis ED, Roque M, Vorchheimer D, Carrick FE, Fallon JT, Fuster V, Badimon JJ. Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation. 2003 Apr 1; 107(12):1658-63.
      View in: PubMed
    402. Chesebro JH, Fuster V, Pugo FJ. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2003 Mar 13; 348(11):1057-9; author reply 1057-9.
      View in: PubMed
    403. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003 Feb 25; 107(7):973-7.
      View in: PubMed
    404. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003 Feb 19; 41(4 Suppl S):7S-14S.
      View in: PubMed
    405. Rastegar R, Harnick DJ, Weidemann P, Fuster V, Coller B, Badimon JJ, Chesebro J, Goldman ME. Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. J Am Coll Cardiol. 2003 Feb 19; 41(4):603-10.
      View in: PubMed
    406. Corti R, Fuster V. New understanding, diagnosis, and prognosis of atherothrombosis and the role of imaging. Am J Cardiol. 2003 Feb 6; 91(3A):17A-26A.
      View in: PubMed
    407. Worthley SG, Helft G, Fuster V, Fayad ZA, Shinnar M, Minkoff LA, Schechter C, Fallon JT, Badimon JJ. A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2003 Feb 1; 23(2):346-50.
      View in: PubMed
    408. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB, Fihn SD, Fraker TD, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003 Jan 7; 107(1):149-58.
      View in: PubMed
    409. Nash IS, Fuster V. Is a chimera the answer? Am Heart Hosp J. 2003; 1(3):203-4.
      View in: PubMed
    410. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002 Dec 3; 106(23):2884-7.
      View in: PubMed
    411. Badimon JJ, Fuster V. Can we image the "active" thrombus? Arterioscler Thromb Vasc Biol. 2002 Nov 1; 22(11):1753-4.
      View in: PubMed
    412. Shimbo D, Osende J, Chen J, Robbins J, Shimoto Y, Kunitada S, Fuster V, Badimon JJ. Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin. Thromb Haemost. 2002 Nov; 88(5):733-8.
      View in: PubMed
    413. Poon M, Fuster V, Fayad Z. Cardiac magnetic resonance imaging: a "one-stop-shop" evaluation of myocardial dysfunction. Curr Opin Cardiol. 2002 Nov; 17(6):663-70.
      View in: PubMed
    414. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RI, Antman EM, Alpert JS, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol. 2002 Nov; 13(11):1183-99.
      View in: PubMed
    415. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002 Oct 16; 40(8):1531-40.
      View in: PubMed
    416. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation. 2002 Oct 15; 106(16):2145-61.
      View in: PubMed
    417. Fayad ZA, Fuster V, Nikolaou K, Becker C. Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts. Circulation. 2002 Oct 8; 106(15):2026-34.
      View in: PubMed
    418. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002 Oct 2; 40(7):1366-74.
      View in: PubMed
    419. Gomberg-Maitland M, Kim MC, Fuster V. A stratified approach to the treatment of a symptomatic myocardial bridge. Clin Cardiol. 2002 Oct; 25(10):484-6.
      View in: PubMed
    420. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 1; 106(14):1883-92.
      View in: PubMed
    421. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation. 2002 Oct 1; 106(14):1893-900.
      View in: PubMed
    422. Corti R, Wyttenbach R, Alerci M, Badimon JJ, Fuster V, Gallino A. Images in cardiovascular medicine. Effect of percutaneous transluminal angioplasty on severely stenotic femoral lesions: in vivo demonstration by noninvasive magnetic resonance imaging. Circulation. 2002 Sep 17; 106(12):1570-1.
      View in: PubMed
    423. Strain JJ, Karim A, Caliendo G, Alexis JD, Lowe RS, Fuster V. Cardiac drug-psychotropic drug update. Gen Hosp Psychiatry. 2002 Sep-Oct; 24(5):283-9.
      View in: PubMed
    424. Fuster V, Corti R, Badimon JJ. The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research. Circ J. 2002 Sep; 66(9):783-90.
      View in: PubMed
    425. Merz CN, Mensah GA, Fuster V, Greenland P, Thompson PD. Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference. J Am Coll Cardiol. 2002 Aug 21; 40(4):641-51.
      View in: PubMed
    426. Fayad ZA, Fuster V. Atherothrombotic plaques and the need for imaging. Neuroimaging Clin N Am. 2002 Aug; 12(3):351-64.
      View in: PubMed
    427. Doshi SN, Kim MC, Sharma SK, Fuster V. Images in cardiovascular medicine. Right and left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Circulation. 2002 Jul 9; 106(2):e3-4.
      View in: PubMed
    428. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002 Jul 1; 22(7):1065-74.
      View in: PubMed
    429. Halperin JL, Fuster V. Patent foramen ovale and recurrent stroke: another paradoxical twist. Circulation. 2002 Jun 4; 105(22):2580-2.
      View in: PubMed
    430. Choudhury RP, Aguinaldo JG, Rong JX, Kulak JL, Kulak AR, Reis ED, Fallon JT, Fuster V, Fisher EA, Fayad ZA. Atherosclerotic lesions in genetically modified mice quantified in vivo by non-invasive high-resolution magnetic resonance microscopy. Atherosclerosis. 2002 Jun; 162(2):315-21.
      View in: PubMed
    431. Borreguero LJ, Corti R, de Soria RF, Osende JI, Fuster V, Badimon JJ. Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging. Circulation. 2002 May 28; 105(21):E177-8.
      View in: PubMed
    432. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002 May 28; 105(21):2504-11.
      View in: PubMed
    433. Redberg RF, Greenland P, Fuster V, Pyörälä K, Blair SN, Folsom AR, Newman AB, O'Leary DH, Orchard TJ, Psaty B, Schwartz JS, Starke R, Wilson PW. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes. Circulation. 2002 May 7; 105(18):e144-52.
      View in: PubMed
    434. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2002 May; 94(5):1052-64.
      View in: PubMed
    435. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002 Apr 17; 39(8):1366-73.
      View in: PubMed
    436. Beller GA, Bonow RO, Fuster V. ACC revised recommendations for training in adult cardiovascular medicine. Core Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement). J Am Coll Cardiol. 2002 Apr 3; 39(7):1242-6.
      View in: PubMed
    437. Baim D, Brady TJ, Casscells SW, Dunne M, Fayad Z, Fuster V, Gazelle S, Heldman A, Hatsukami T, Kinlay S, Lafont A, Lee R, Libby P, Meier B, Muller JE, Naghavi M, O'Donnell C, Perin E, Rekhter M, Rumberger J, Russell M, Schwartz R, Selwyn A, Strauss HW, Tearney G, Tomaru T, Tuzcu EM, Wasserman B. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10.
      View in: PubMed
    438. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation. 2002 Mar 12; 105(10):1257-67.
      View in: PubMed
    439. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002 Feb 26; 105(8):993-8.
      View in: PubMed
    440. Poon M, Badimon JJ, Fuster V. Overcoming restenosis with sirolimus: from alphabet soup to clinical reality. Lancet. 2002 Feb 16; 359(9306):619-22.
      View in: PubMed
    441. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002 Feb 6; 39(3):542-53.
      View in: PubMed
    442. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant. 2002 Feb; 21(2):189-203.
      View in: PubMed
    443. Shimbo D, Child J, Davidson K, Geer E, Osende JI, Reddy S, Dronge A, Fuster V, Badimon JJ. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol. 2002 Feb 1; 89(3):331-3.
      View in: PubMed
    444. Fuster V, Rosenbluth A. Aortic valve disease--etiology and the role of vascular pathology: is the face of the disease changing? Adv Cardiol. 2002; 39:25-38.
      View in: PubMed
    445. Corti R, Fuster V, Badimon JJ, Hutter R, Fayad ZA. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann N Y Acad Sci. 2001 Dec; 947:181-95; discussion 195-8.
      View in: PubMed
    446. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res. 2001 Aug 17; 89(4):305-16.
      View in: PubMed
    447. Fayad ZA, Fuster V. The human high-risk plaque and its detection by magnetic resonance imaging. Am J Cardiol. 2001 Jul 19; 88(2A):42E-45E.
      View in: PubMed
    448. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001 Jul 17; 104(3):249-52.
      View in: PubMed
    449. Roqué M, Reis ED, Cordon-Cardo C, Taubman MB, Fallon JT, Fuster V, Badimon JJ. Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest. 2001 Jun; 81(6):895-903.
      View in: PubMed
    450. Worthley SG, Helft G, Fayad ZA, Fuster V, Rodriguez OJ, Zaman AG, Badimon JJ. Cardiac gated breath-hold black blood MRI of the coronary artery wall: an in vivo and ex vivo comparison. Int J Cardiovasc Imaging. 2001 Jun; 17(3):195-201.
      View in: PubMed
    451. Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med. 2001 May; 68(3):167-81.
      View in: PubMed
    452. Osende JI, Fuster V, Lev EI, Shimbo D, Rauch U, Marmur JD, Richard M, Varon D, Badimon JJ. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation. 2001 Mar 20; 103(11):1488-91.
      View in: PubMed
    453. Fonseca FA, Izar MC, Fuster V, Gallo R, Padurean A, Fallon JT, Schachter EN, Chesebro JH, Badimon JJ. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis. 2001 Jan; 154(1):61-9.
      View in: PubMed
    454. Reis ED, Roqué M, Cordon-Cardo C, Drobnjak M, Fuster V, Badimon JJ. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vasc Surg. 2000 Nov; 32(5):1022-9.
      View in: PubMed
    455. Rauch U, Osende JI, Chesebro JH, Fuster V, Vorchheimer DA, Harris K, Harris P, Sandler DA, Fallon JT, Jayaraman S, Badimon JJ. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 2000 Nov; 153(1):181-9.
      View in: PubMed
    456. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000 Aug 1; 102(5):506-10.
      View in: PubMed
    457. Rauch U, Crandall J, Osende JI, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. Am J Cardiol. 2000 Jul 15; 86(2):246-9.
      View in: PubMed
    458. Sharma SK, Kini A, Marmur JD, Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation. 2000 Jul 11; 102(2):166-72.
      View in: PubMed
    459. Roqué M, Rauch U, Reis ED, Chesebro JH, Fuster V, Badimon JJ. Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury. Thromb Res. 2000 Jun 15; 98(6):499-505.
      View in: PubMed
    460. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation. 2000 May 30; 101(21):2503-9.
      View in: PubMed
    461. Fayad ZA, Fuster V. Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci. 2000 May; 902:173-86.
      View in: PubMed
    462. Zaman AG, Osende JI, Chesebro JH, Fuster V, Padurean A, Gallo R, Worthley SG, Helft G, Rodriguez OX, Fallon JT, Badimon JJ. In vivo dynamic real-time monitoring and quantification of platelet-thrombus formation: use of a local isotope detector. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):860-5.
      View in: PubMed
    463. Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation. 2000 Feb 15; 101(6):586-9.
      View in: PubMed
    464. Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, Badimon JJ, Harrington M, Harrington E, Fuster V. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol. 1999 Nov; 19(11):2756-61.
      View in: PubMed
    465. Badimon JJ, Zaman A, Helft G, Fayad Z, Fuster V. Acute coronary syndromes: pathophysiology and preventive priorities. Thromb Haemost. 1999 Aug; 82(2):997-1004.
      View in: PubMed
    466. Zaman AG, Helft G, Osende JI, Fuster V, Badimon JJ. Histopathology and pathogenesis of plaque instability and thrombus formation. Drugs Today (Barc). 1999 Aug; 35(8):641-56.
      View in: PubMed
    467. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999 Apr 27; 99(16):2164-70.
      View in: PubMed
    468. Vorchheimer DA, Badimon JJ, Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA. 1999 Apr 21; 281(15):1407-14.
      View in: PubMed
    469. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999 Apr 13; 99(14):1780-7.
      View in: PubMed
    470. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998 Oct 13; 98(15):1541-7.
      View in: PubMed
    471. Badimon JJ, Ortiz AF, Meyer B, Mailhac A, Fallon JT, Falk E, Badimon L, Chesebro JH, Fuster V. Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis. 1998 Oct; 140(2):307-14.
      View in: PubMed
    472. Harnick DJ, Cohen JL, Schechter CB, Fuster V, Smith DA. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease. Am J Cardiol. 1998 Jun 15; 81(12):1416-20.
      View in: PubMed
    473. Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation. 1998 Feb 17; 97(6):581-8.
      View in: PubMed
    474. Mehta D, Curwin J, Gomes JA, Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation. 1997 Nov 4; 96(9):3215-23.
      View in: PubMed
    475. Badimon JJ, Meyer B, Feigen LP, Baron DA, Chesebro JH, Fuster V, Badimon L. Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist. Eur J Clin Invest. 1997 Jul; 27(7):568-74.
      View in: PubMed
    476. Nash IS, Nash DB, Fuster V. Do cardiologists do it better? J Am Coll Cardiol. 1997 Mar 1; 29(3):475-8.
      View in: PubMed
    477. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997 Feb 4; 95(3):594-9.
      View in: PubMed
    478. Chesebro JH, Toschi V, Lettino M, Gallo R, Badimon JJ, Fallon JT, Fuster V. Evolving concepts in the pathogenesis and treatment of arterial thrombosis. Mt Sinai J Med. 1995 Sep; 62(4):275-86.
      View in: PubMed
    479. McLaughlin MA, Fuster V. The three mechanisms for coronary artery disease progression: insights into future management. Mt Sinai J Med. 1995 Sep; 62(4):265-74.
      View in: PubMed
    480. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost. 1995 Jul; 74(1):552-9.
      View in: PubMed
    481. Cohen M, Merino A, Hawkins L, Greenberg S, Fuster V. Clinical and angiographic characteristics and outcome of patients with rest-unstable angina occurring during regular aspirin use. J Am Coll Cardiol. 1991 Nov 15; 18(6):1458-62.
      View in: PubMed
    482. Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Blood. 1991 Jul 15; 78(2):423-34.
      View in: PubMed
    483. Cohen M, Hawkins L, Greenberg S, Fuster V. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. Am J Cardiol. 1991 Jun 15; 67(16):1368-73.
      View in: PubMed
    484. Israel DH, Adams PC, Stein B, Chesebro JH, Fuster V. Antithrombotic therapy in the coronary vein graft patient. Clin Cardiol. 1991 Apr; 14(4):283-95.
      View in: PubMed
    485. Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb. 1991 Mar-Apr; 11(2):395-402.
      View in: PubMed
    486. Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol. 1990 Dec 1; 66(19):1287-92.
      View in: PubMed
    487. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990 Apr; 85(4):1234-41.
      View in: PubMed
    488. Fuster V, Stein B, Halperin JL, Chesebro JH. Antithrombotic therapy in cardiac disease: an approach based on pathogenesis and risk stratification. Am J Cardiol. 1990 Feb 2; 65(6):38C-44C.
      View in: PubMed
    489. Cohen M, Fuster V. Insights into the pathogenetic mechanisms of unstable angina. Haemostasis. 1990; 20 Suppl 1:102-12.
      View in: PubMed
    490. Milner MR, Gelman KM, Phillips RA, Fuster V, Davies TF, Goldman ME. Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms. Pharmacotherapy. 1990; 10(2):100-6.
      View in: PubMed
    491. Badimon L, Badimon JJ, Fuster V. Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches. Z Kardiol. 1990; 79 Suppl 3:133-45.
      View in: PubMed
    492. Stein B, Fuster V. Role of platelet inhibitor therapy in myocardial infarction. Cardiovasc Drugs Ther. 1989 Dec; 3(6):797-813.
      View in: PubMed
    493. Gomes JA, Alexopoulos D, Winters SL, Deshmukh P, Fuster V, Suh K. The role of silent ischemia, the arrhythmic substrate and the short-long sequence in the genesis of sudden cardiac death. J Am Coll Cardiol. 1989 Dec; 14(7):1618-25.
      View in: PubMed
    494. Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation. 1989 Oct; 80(4):840-5.
      View in: PubMed
    495. Badimon L, Badimon JJ, Turitto VT, Fuster V. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions. Blood. 1989 Mar; 73(4):961-7.
      View in: PubMed
    496. Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest. 1989 Mar; 60(3):455-61.
      View in: PubMed
    497. Badimon L, Badimon JJ, Galvez A, Turitto V, Fuster V. Platelet interaction with vessel wall and collagen in pigs with homozygous von Willebrand's disease associated with abnormal collagen aggregation. Thromb Haemost. 1989 Feb 28; 61(1):57-64.
      View in: PubMed
    498. Weinberger J, Ramos L, Ambrose JA, Fuster V. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real time B-mode ultrasonography. J Am Coll Cardiol. 1988 Dec; 12(6):1515-21.
      View in: PubMed
    499. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol. 1988 Nov; 12(5):1193-8.
      View in: PubMed
    500. Schwinger M, Cohen M, Fuster V. Usefulness of onset of the pulmonary wedge V wave in predicting mitral regurgitation. Am J Cardiol. 1988 Sep 15; 62(9):646-8.
      View in: PubMed
    501. Vallabhajosula S, Paidi M, Badimon JJ, Le NA, Goldsmith SJ, Fuster V, Ginsberg HN. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med. 1988 Jul; 29(7):1237-45.
      View in: PubMed
    502. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988 Jun; 77(6):1213-20.
      View in: PubMed
    503. Stein B, Israel DH, Cohen M, Fuster V. Ischemia and infarction III. Pathogenesis of coronary occlusion. Hosp Pract (Off Ed). 1988 Apr 15; 23(4):87-99.
      View in: PubMed
    504. Fuster V, Cohen M, Chesebro JH. Usefulness of aspirin for coronary artery disease. Am J Cardiol. 1988 Mar 1; 61(8):637-40.
      View in: PubMed
    505. Charney R, Leddomado E, Rose DN, Fuster V. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol. 1988 Feb; 18(2):197-206.
      View in: PubMed
    506. Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med. 1987 Dec; 110(6):706-18.
      View in: PubMed
    507. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease--long-term follow-up and prediction of outcome after surgical correction. Circulation. 1987 Nov; 76(5):1037-42.
      View in: PubMed
    508. Adams PC, Fuster V, Badimon L, Badimon JJ, Chesebro JH. Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. Am J Cardiol. 1987 Oct 30; 60(12):9G-16G.
      View in: PubMed
    509. Monsen CH, Adams PC, Badimon L, Chesebro JH, Fuster V. Platelet-vessel wall interactions in the development of restenosis after coronary angioplasty. Z Kardiol. 1987; 76 Suppl 6:23-8.
      View in: PubMed
    510. Dewanjee MK, Wahner HW, Dunn WL, Robertson JS, Offord KP, Fuster VD, Chesebro JH. Comparison of three platelet markers for measurement of platelet survival time in healthy volunteers. Mayo Clin Proc. 1986 May; 61(5):327-36.
      View in: PubMed
    511. Dewanjee MK, Pumphrey CW, Murphy KP, Rosemark JA, Chesebro JH, Fuster VD, Kaye MP. Evaluation of platelet-inhibitor drugs in a canine bilateral femoral graft implant model. Trans Am Soc Artif Intern Organs. 1982; 28:504-9.
      View in: PubMed
    512. Fuster VD, Bowie EJ. Interaction of platelets with the endothelium in normal and von Willebrand pigs. Adv Exp Med Biol. 1978; 102:187-95.
      View in: PubMed
    Fuster's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067